Annual Reports

Annual Report for the year ended 30 June 2011

Contents: INTRODUCTION | ERYTHROPOIETIC PROTOPORPHYRIA (EPP) | NONSEGMENTAL VITILIGO (NSV) | CLINUVEL BUSINESS MODEL | CORPORATE MILESTONES | CHAIR's LETTER | MANAGING DIRECTOR’S REPORT | FINANCIALS | ADDITIONAL INFORMATION REQUIRED BY THE ASX | MARKET PERFORMANCE | GLOSSARY

Annual Report for the year ended 30 June 2010

Annual Report for the year ended 30 June 2010.

Annual Report for the year ended 30 June 2009

Annual Report for the year ended 30 June 2009.

Annual Report for the year ended 30 June 2008

Annual Report for the year ended 30 June 2008.

Annual Report for the year ended 30 June 2007

Annual Report for the year ended 30 June 2007.

Annual Report for the year ended 30 June 2006

Annual Report for the year ended 30 June 2006.
<< Start < Prev 1 2 Next > End >>
Page 1 of 2

Investors Related Blog Posts

Image

MAA: a moment in Clinuvel’s EPP...

Those who have taken an interest in Clinuvel will have learned with joy that, on Monday February 6th, the... Read more...

Image

Online evolution...

Earlier this week we unveiled a major update to our online presence with the release of our new-look website... Read more...

Image

EPP results and clinical relevanc...

Over recent months I have written several times of the need for Clinuvel to prove clinical relevance in... Read more...

Investors Related Videos

Part Four - The impact of Eryt...

Mikey's quality of life, like all patients with Erythropoietic Protoporphyria (EPP), is severely affected. Severe pain f... Watch now

Quick! I need Sunburn Relief! ...

There are many remedies available to help provide relief from the symptoms of sunburn. Treatment of sunburn can include:... Watch now

Understanding Vitiligo - Cause...

Vitiligo is a common pigmentary disorder in which the pigment producing cells of the skin (melanocytes) are absent or do... Watch now

JoomlaXTC K2 Content Wall - Copyright 2010 Monev Software LLC

Featured Content

Annual Report for the year ended 30 June 2011

Contents: INTRODUCTION | ERYTHROPOIETIC PROTOPORPHYRIA (EPP) | NONSEGMENTAL VITILIGO (NSV) | CLINUVEL BUSINESS MODEL | CORPORATE MILESTONES | CHAIR's LETTER | MANAGING DIRECTOR’S REPORT | FINANCIALS | ADDITIONAL INFORMATION REQUIRED BY THE ASX | MA... Read more

JoomlaXTC K2 Content Wall - Copyright 2010 Monev Software LLC